Avalon GloboCare Corp. (AVCO)
NASDAQ: AVCO
· Real-Time Price · USD
0.53
-0.10 (-15.87%)
At close: Nov 10, 2022, 6:00 AM
Avalon GloboCare Revenue Breakdown
| Period Ending | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|
| MedicalRelatedConsultingServicesMember Revenue | 187.41K | 1.21M |
| MedicalRelatedConsultingServicesMember Revenue Growth | -84.47% | n/a |
| RealPropertyOperationsMember Revenue | 1.2M | n/a |
| RealPropertyOperationsMember Revenue Growth | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.01M | 1.93M | 2.08M | 860.19K | 648.42K | 542.63K | 1.07M | 1.76M | 2.17M | 224.52K | 1.49M | 1.32M | 1.57M | 2.01M | 1.91M | 2.14M | 2.16M | 2.96M | 3.14M | 2.87M | 2.99M | 4.87M | 4.25M | 3.47M | 4.32M | 2.78M | 2.5M | 1.35M | 1.4M | 1.12M | 747.61K | 476.38K | 459.59K | 439.9K | 1.1K | 6.75K | 18.69K | 6.94K | 12.27K | 4.75K | 7.05K |
| Selling, General, and Administrative Revenue Growth | +4.42% | -7.40% | +142.04% | +32.66% | +19.50% | -49.24% | -39.36% | -18.68% | +865.61% | -84.92% | +12.97% | -15.84% | -22.17% | +5.34% | -10.71% | -1.11% | -26.93% | -5.76% | +9.44% | -3.98% | -38.67% | +14.57% | +22.45% | -19.64% | +55.56% | +11.29% | +85.37% | -3.51% | +24.53% | +49.94% | +56.94% | +3.65% | +4.47% | +39746.29% | -83.64% | -63.88% | +169.27% | -43.41% | +158.21% | -32.62% | n/a |
| Research and Development Revenue | n/a | n/a | 110.16K | n/a | n/a | 542 | n/a | 17.81K | 92.35K | 189.76K | 170.41K | 254.48K | 116.68K | 348.96K | 224.07K | 238.79K | 213.19K | 208.92K | 238.43K | 161.1K | 275.4K | 414.56K | 265.14K | 949.71K | 152.46K | 171.52K | 69.66K | 75.22K | 11.29K | 26.28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | -100.00% | n/a | n/a | -100.00% | n/a | -100.00% | -80.71% | -51.33% | +11.36% | -33.04% | +118.09% | -66.56% | +55.73% | -6.16% | +12.01% | +2.04% | -12.38% | +48.00% | -41.50% | -33.57% | +56.36% | -72.08% | +522.92% | -11.11% | +146.22% | -7.40% | +566.30% | -57.03% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 322.55K | 71.15K | -1.4M | 62.66K | 45K | 32K | 437.75K | 505.22K | 691.75K | 517.49K | 150.62K | 130.4K | 526.81K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 221.22K | 244.6K | -151K | 150.55K | n/a | n/a | n/a | 148 | 6.28K | 8.71K | 6.89K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | +353.34% | -105.09% | -2329.49% | +39.24% | +40.62% | -92.69% | -13.35% | -26.97% | +33.67% | +243.57% | +15.51% | -75.25% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | -9.56% | -261.99% | -200.30% | n/a | n/a | n/a | -100.00% | -97.64% | -27.92% | +26.36% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |